Posted inStock
Lilly sues US agency over blocking of drug-rebate program
(Reuters) – Eli Lilly (NYSE:LLY) said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company’s plan to change the way it offers…